Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-876
Closed -$66.2K 1944
2026
Q1
$66.2K Buy
+876
New +$65.9K ﹤0.01% 997
2025
Q4
Sell
-647
Closed -$43.7K 1075
2025
Q3
$43.7K Buy
+647
New +$43K ﹤0.01% 932
2025
Q2
Sell
-717
Closed -$44.3K 1088
2025
Q1
$44.3K Sell
717
-2,220
-76% -$147K ﹤0.01% 915
2024
Q4
$212K Buy
2,937
+2,063
+236% +$161K ﹤0.01% 549
2024
Q3
$71.2K Buy
874
+86
+11% +$6.88K ﹤0.01% 812
2024
Q2
$61.4K Buy
788
+121
+18% +$9.07K ﹤0.01% 944
2024
Q1
$47.6K Buy
+667
New +$49.6K ﹤0.01% 883

Other funds holding HOLX

Mather Group's HOLX Position: Q2 2026 in Review

Mather Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 876 shares — an estimated $66.2K sold.

Mather Group first reported a position in HOLX in Q1 2024 and held it in 7 quarters. The position peaked at $212K in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Mather Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Mather Group sold 876 Hologic shares in Q2 2026, an estimated $66.2K.
  • Mather Group first reported a position in Hologic in Q1 2024 and held it in 7 quarters.
  • Mather Group's Hologic position peaked at $212K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.